Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (10.877)

41

Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer

enthalten in: Cancer biology & therapy | 2009

von Kim, T. | Landen, C. | Lin, Y. | +10

CommentIn: Cancer Biol Ther. 2009 Dec;8(23):2273-4. - PMID 19907207

42

Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Morris, P. | Dickler, M. | McArthur, H. | +14

CommentIn: J Clin Oncol. 2009 Dec 20;27(36):6073-5. - PMID 19901128

43

Value of serum human epidermal growth factor receptor 2 (HER2)/neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Ali, S. | Leitzel, K. | Lipton, A. | +2

CommentOn: J Clin Oncol. 2009 Apr 1;27(10):1685-93. - PMID 19255335

44

Trastuzumab for patients with axillary-node-positive breast cancer : results of the FNCLCC-PACS 04 trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Spielmann, M. | Roché, H. | Delozier, T. | +17

CommentIn: J Clin Oncol. 2010 Jul 20;28(21):e353-4. - PMID 20406919

45

Clinical utility of serum human epidermal growth factor receptor 2 extracellular domain levels : stop the shilly-shally--it is time for a well-designed, large-scale prospective study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Tse, C. | Lamy, P.

CommentOn: J Clin Oncol. 2009 Apr 1;27(10):1694-705. - PMID 19255333

46

Adalimumab in the management of cutaneous and oral lichen planus

enthalten in: Cutis | 2009

von Chao, T.

47

The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Dredge, K. | Kink, J. | Johnson, R. | +2

48

Metabolic bone diseases : translational research-preventing fractures with denosumab

enthalten in: Nature reviews. Rheumatology | 2009

von Ebeling, P.

49

Asymptomatic reactivation of JC virus in patients treated with natalizumab

enthalten in: The New England journal of medicine | 2009

von Gorelik, L. | Goelz, S. | Sandrock, A.

CommentOn: N Engl J Med. 2009 Sep 10;361(11):1067-74. - PMID 19741227

50

Melanoma in multiple sclerosis treated with natalizumab : causal association or coincidence?

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2009

von Bergamaschi, R. | Montomoli, C.

CommentIn: Mult Scler. 2011 Feb;17(2):255-6. - PMID 21177318